Filter
118
Filtered Results: 118
Text search:
anti-interleukin
Featured
Recommendations
18
New Publications
11
Language
Document type
No document type
43
Guidelines
29
Studies & Reports
28
Manuals
10
Strategic & Response Plan
3
Situation Updates
2
Fact sheets
2
Training Material
1
Countries / Regions
India
8
Global
6
Brazil
6
Germany
5
Kenya
2
Philippines
2
Bangladesh
2
South Africa
2
Uganda
2
Indonesia
2
El Salvador
1
Syria
1
Nigeria
1
Qatar
1
Mozambique
1
Africa
1
Venezuela
1
Latin America and the Carribbean
1
Tanzania
1
West and Central Africa
1
South–East Asia Region
1
Western and Central Europe
1
Portugal
1
East and Southern Africa
1
Bolivia
1
Russia
1
Yemen
1
Angola
1
Zambia
1
South Sudan
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
35
Clinical Guidelines
12
Public Health
11
Women & Child Health
4
Pharmacy & Technologies
2
Key Resources
1
Toolboxes
COVID-19
33
NTDs
10
HIV
9
NCDs
9
TB
8
Planetary Health
6
Mental Health
5
Refugee
3
Ebola & Marburg
3
Pharmacy
3
Conflict
3
Specific Hazards
2
Global Health Education
2
Rapid Response
1
Cholera
1
AMR
1
Lancet. 2014 June 28; 383(9936): 2253–2264. doi:10.1016/S0140-6736(13)61949-2. Review Article
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
16.7.2021
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
PLoS Pathogens | www.plospathogens.org 1
February 2012 | Volume 8 | Issue 2 | e100246
5 May 2021
This Information Note is intended to assist national TB programmes and health personnel worldwide to maintain essential tuberculosis (TB) services during the COVID-19 pandemic and in the recovery phase. It is important that recent progress made in TB prevention and care is not reversed b...
Jin et al. Military Medical Research (2020) 7:4 https://doi.org/10.1186/s40779-020-0233-6
Position Article und Guideline
Biology, Diagnosis and Treatment, Epidemiology and Prevention
Cureus 2024 Jan 16;16(1):e52358. doi: 10.7759/cureus.52358
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
With this quick reference guide, providers can easily recognize diseases and side effects related to climate change, implement appropriate management and provide guidance to exposed populations, provide up-to-date information on the relationship between the adverse effects of certain drugs and the w...
